EDAP TMS S.A. (EDAP)
| Market Cap | 182.24M |
| Revenue (ttm) | 50.81M |
| Net Income (ttm) | -2.08M |
| Shares Out | 33.35M |
| EPS (ttm) | 0.00 |
| PE Ratio | 1,366.25 |
| Forward PE | 27.55 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 38,518 |
| Open | 5.44 |
| Previous Close | 5.48 |
| Day's Range | 5.27 - 5.50 |
| 52-Week Range | 4.45 - 10.68 |
| Beta | 1.54 |
| Analysts | Buy |
| Price Target | 8.75 (+60.1%) |
| Earnings Date | Nov 17, 2021 |
About EDAP
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three divisions: High Intensity Focused Ultrasound (HIFU); Extracorporeal ShockWave Lithotripsy (ESWL); and Distribution. The HIFU division develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinic...
Analyst Forecast
According to 2 analysts, the average rating for EDAP TMS stock is "Buy." The 12-month stock price forecast is 8.75, which is an increase of 60.11% from the latest price.
News
EDAP to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
LYON, France, November 29, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the company will participate in a fireside chat a...
EDAP Reports Third Quarter 2021 Results and Provides Operational Update
LYON, France, November 17, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today unaudited financial results for the third quarter of 202...
EDAP TMS SA to Announce Third Quarter 2021 Financial Results on Wednesday, November 17, 2021
Company to host conference call and webcast on Thursday, November 18, at 8:30 am ET
EDAP Announces University of Washington Medicine to Launch Focal One® Robotic HIFU Program
Brings advanced focal ablation to prostate cancer patients in the Pacific Northwest
EDAP to Participate at Upcoming Investor Conferences
LYON, France, September 7, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), a global leader in robotic energy-based therapies, today announced that management will present at the following investor c...
EDAP Reports Second Quarter 2021 Results and Provides Operational Update
LYON, France, August 25, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today unaudited financial results for the second quarter of 2021...
EDAP Announces Select Preliminary Unaudited Second Quarter 2021 Results
LYON, France, August 4, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, reports today select preliminary unaudited second quarter financial and o...
EDAP Issues Letter to Shareholders
Successful financing and hiring of MedTech industry veteran Ryan Rhodes to drive accelerated U.S. expansion efforts
Recap: Edap TMS Q1 Earnings
Shares of Edap TMS (NASDAQ:EDAP) rose after the company reported Q1 results. Quarterly Results Earnings per share increased 160.00% year over year to $0.03, which beat the estimate of ($0.01).
EDAP Reports First Quarter 2021 Results and Provides Operational Update
LYON, France, May 11, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today unaudited financial results for the first quarter of 2021 and...
EDAP TMS SA to Announce First Quarter 2021 Financial Results on May 11, 2021
Company to host conference call and webcast on Wednesday , May 12 at 8:30 am EDT
EDAP Announces Pricing of Follow-On Offering
LYON, France, April 23, 2021 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced that the price of its offering of American Depositary Shares (“...
EDAP Announces Launch of Follow-On Offering
LYON, France, April 22, 2021 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today the launch of a follow-on public offering of its American...
Recap: Edap TMS Q4 Earnings
Shares of Edap TMS (NASDAQ:EDAP) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 175.00% over the past year to $0.03, which missed the ...
EDAP Reports Fourth Quarter 2020 Results and Provides Operational Update
LYON, France, March 30, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today unaudited financial results for the fourth quarter of 2020 ...
EDAP TMS S.A. (EDAP) Stock Jumps 18.8%: Will It Continue to Soar?
EDAP TMS S.A. (EDAP) was a big mover last session on higher-than-average trading volume.
A Preview Of Edap TMS's Earnings
Edap TMS (NASDAQ:EDAP) releases its next round of earnings this Tuesday, March 30. Here is Benzinga's essential guide to Edap TMS's Q4 earnings report.
EDAP Selects Leading Reimbursement Consultancies MTP and Argenta Advisors to Expand Market Access and Coverage of HIF...
EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, announces today that the company has selected Medical Technology Partners (MTP) and Argenta Advisors, two...
EDAP to Participate in B. Riley Securities Virtual Oncology Investor Conference
LYON, France, January 19, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, today announced that Marc Oczachowski, President and CEO, will particip...
EDAP Announces Positive 24 Month Interim Results of French Urology Association (AFU) Sponsored Clinical Study compari...
LYON, France, January 14, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, announced today positive 24 month interim results from the “HIFI” study...
EDAP TMS (EDAP) Surges: Stock Moves 6% Higher
EDAP TMS (EDAP) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
EDAP to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event
LYON, France, January 5, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, today announced that it will participate in the 10th Annual LifeSci Part...
EDAP Announces End of the Year Focal One® Sales
LYON, France, December 30, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy- based therapies, announced today two new Focal One sales to leading U.S. healthcare in...
EDAP Announces Final U.S. 2021 Reimbursement Rules for High Intensity Focused Ultrasound (HIFU)
Final rules establish, for the first time, a Category 1 CPT code and reimbursement to physicians performing ablation of malignant prostate tissue with HIFU in the US
Edap TMS: Q3 Earnings Insights
Shares of Edap TMS (NASDAQ:EDAP) were flat after the company reported Q3 results. Quarterly Results Earnings per share decreased 233.33% over the past year to ($0.04), which missed the estimate of ($0.02).